Grazoprevir is a macrocyclic compound used as an active pharmaceutical ingredient in the manufacturing of antiviral medications. It functions as an inhibitor of the hepatitis C virus NS3/4A protease and is a component of combination regimens for research and pharmaceutical production.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1350462-55-3
Grazoprevir
Hepatitis C virus NS3/4A protease inhibitor
Repaglinide
active pharmaceutical ingredient
Lefamulin acetate
Antibiotic active pharmaceutical ingredient
Vericiguat
soluble guanylate cyclase stimulator
Ceralasertib
active pharmaceutical ingredient
Voxilaprevir
HCV NS3/4A protease inhibitor
(1R,18R,20R,24S,27S)-24-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetrazapentacyclo[24.2.1.03,12.05,10.018,20]nonacosa-3,5(10),6,8,11-pentaene-27-carboxamide
OBMNJSNZOWALQB-NCQNOWPTSA-N
CC(C)(C)[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCC[C@@H]7C[C@H]7OC(=O)N1